Gene expression profiles of all types of tumor samples showed that MFAP4 expression was significantly elevated in high-grade gliomas, especially in GBM (Figure 2A), and furthermore, MFAP4 expression increased with WHO grade (Figure 2B). This evidence concerns the gene MFAP4 and central nervous system cancer.